MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the rate of therapeutic cure of the
combination treatment of MGCD290 and fluconazole as compared to that of fluconazole alone at
Test of Cure Visit for patients with moderate to severe vulvovaginal candidiasis.